Exicon Co., Ltd. (KOSDAQ:092870)

Checkpoint Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29,331	8,666	29,560	4,947	10,537	19,012
Short-Term Investments	7,000	30,000	-	10,000	3,000	18,000
Trading Asset Securities	605.02	671.82	-	3,218	-	-
Cash & Short-Term Investments	36,936	39,338	29,560	18,165	13,537	37,012
Cash Growth	50.38%	33.08%	62.73%	34.19%	-63.42%	17.89%
Accounts Receivable	248.35	5,979	2,883	14,027	13,410	6,188
Receivables	248.35	5,979	2,883	14,027	13,410	6,188
Inventory	19,614	16,157	23,922	34,542	12,965	7,610
Prepaid Expenses	839.43	542.23	436.16	314.91	124.1	69.68
Other Current Assets	2,989	3,326	1,474	2,825	7,931	923.51
Total Current Assets	60,626	65,342	58,275	69,873	47,967	51,802
Property, Plant & Equipment	53,434	53,649	50,893	47,686	50,474	26,521
Long-Term Investments	53,042	52,162	42,884	43,833	46,425	26,192
Other Intangible Assets	361.36	279	377.91	630.88	501.82	570.24
Long-Term Accounts Receivable	0	0	0	0	425.56	1,021
Long-Term Deferred Tax Assets	15,565	12,197	5,162	1,285	1,538	7,309
Other Long-Term Assets	6,777	7,155	8,393	6,310	6,148	4,201
Total Assets	189,805	190,784	165,985	169,618	153,480	117,616
Accounts Payable	3,264	1,359	1,776	11,283	5,166	5,356
Short-Term Debt	4,750	4,750	4,626	4,000	4,000	4,322
Current Income Taxes Payable	-	-	-	271.44	373.89	60.23
Current Unearned Revenue	414.48	351.13	-	-	-	-
Other Current Liabilities	4,239	4,532	9,485	4,363	4,114	6,506
Total Current Liabilities	12,667	10,992	15,887	19,917	13,653	16,244
Long-Term Debt	2,437	2,625	3,374	4,000	4,000	-
Other Long-Term Liabilities	574.82	350.02	766.1	915.79	288.21	298.09
Total Liabilities	15,679	13,967	20,027	24,833	18,119	16,780
Common Stock	6,525	6,525	5,424	5,424	5,238	5,187
Additional Paid-In Capital	71,778	71,778	39,937	39,937	37,179	37,169
Retained Earnings	102,674	105,505	108,078	104,590	90,410	57,075
Treasury Stock	-5,760	-5,760	-5,760	-4,764	-2,307	-1,743
Comprehensive Income & Other	-1,092	-1,231	-1,722	-402.77	2,018	331.99
Total Common Equity	174,126	176,817	145,958	144,785	132,537	98,020
Minority Interest	-	-	-	-	-	124.65
Shareholders' Equity	174,126	176,817	145,958	144,785	135,361	100,837
Total Liabilities & Equity	189,805	190,784	165,985	169,618	153,480	117,616
Total Debt	7,187	7,374	8,000	8,000	8,000	4,322
Net Cash (Debt)	29,749	31,963	21,560	10,165	5,537	32,690
Net Cash Growth	78.95%	48.25%	112.09%	83.59%	-83.06%	37.34%
Net Cash Per Share	2510.50	2828.83	2090.58	968.70	519.35	3067.76
Filing Date Shares Outstanding	12.5	12.5	10.3	10.41	10.25	10.19
Total Common Shares Outstanding	12.5	12.5	10.3	10.41	10.25	10.3
Working Capital	47,959	54,350	42,389	49,956	34,314	35,558
Book Value Per Share	13927.42	14142.66	14170.10	13911.75	12928.76	9519.58
Tangible Book Value	173,765	176,538	145,580	144,154	132,035	97,450
Tangible Book Value Per Share	13898.52	14120.34	14133.41	13851.13	12879.81	9464.20
Land	23,014	22,969	22,794	21,734	27,054	4,953
Buildings	28,083	28,069	28,341	27,372	25,548	19,158
Machinery	17,462	17,467	14,228	13,024	18,147	18,361
Construction In Progress	5,008	4,628	2,698	1,799	701.17	5,395

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.